The question of which skincare ingredients to recommend before and after aesthetic procedures rarely gets a systematic answer. Most protocols are handed down by device manufacturers, shaped by brand partnerships, or left to provider preference.
A 2026 international expert consensus in the Journal of Cosmetic Dermatology — funded by SkinCeuticals and authored by 14 independent clinicians from 10 countries — applied a structured methodology to this question across four procedure categories and four treatment time points. The findings give providers a defensible clinical framework for something most practices handle inconsistently.
What you will learn in this article:
The panel comprised 14 experts — 13 board-certified dermatologists and one aesthetic doctor — from 10 countries across 5 continents, all with more than 10 years of experience integrating skincare with aesthetic procedures.
Using a simplified Delphi method, they evaluated 44 topical active ingredients across four procedure categories and four treatment time points, drawing on 68 integrated skincare clinical studies (46 RCTs) published between 2003 and 2025. Sixty-six percent of those studies included patients with skin of color.
A few disclosures belong upfront. The study was funded by SkinCeuticals, all panelists were invited by SkinCeuticals, and two SkinCeuticals employees contributed to the study’s design and data interpretation. Those two employees were not on the voting panel — the 14 voting clinicians are independent practitioners — but the funding relationship is relevant context when weighing the findings.
The methodology is sound, the panelists are credentialed, and the ingredient recommendations align with the underlying evidence base; readers should simply know who paid for it.
The consensus organized procedures into four categories based on barrier disruption and mechanism: ablative energy-based (CO2 laser, Er:YAG), non-ablative energy-based (RF microneedling, IPL, Nd:YAG), non-energy-based without barrier disruption (neuromodulators, fillers), and non-energy-based with barrier disruption (microneedling, chemical peels).
Skincare recommendations were assessed at four time points: pretreatment (Day −14 to −1), treatment day (Day 0), aftercare (Day 1–7), and followup (Day 8–28). This four-point framework is the most clinically useful part of the consensus — it forces a more precise question than “what should my patients use after their procedure?” The answer depends on which procedure, and on whether it’s the day of treatment, the week after, or the month following.
Five ingredients reached consensus as appropriate across all four procedure categories and all four time points: ceramides, cholesterol, hyaluronic acid, niacinamide, and peptides. Alpha-bisabolol and panthenol also reached consensus as appropriate at all time points and categories per the full text.
These aren’t exotic actives. They’re widely available in medical-grade and over-the-counter formulations. The clinical value of this finding isn’t in the ingredient list — it’s in the permission structure. Ceramides, HA, niacinamide, and peptides are appropriate to use or recommend regardless of procedure type, without timing caveats. That’s a starting point for a standardized protocol.
Beyond the all-time-point group, the panel’s top-ranked actives shift by phase. Ceramides and hyaluronic acid are highly ranked throughout treatment and aftercare. Ferulic acid and vitamin C are consistently in the top five across categories — vitamin C at all time points except pretreatment for non-energy-based procedures without barrier disruption. At pretreatment and followup, retinoids and ferulic acid are the top-ranked actives across all four procedure categories.
This is the most actionable finding for providers who haven’t formalized their protocols. Retinoids are among the highest-ranked ingredients at pretreatment and at followup. The panel discussed the superiority of retinoic acid for increasing cell turnover and collagen production. At the same time, retinoids are identified as unsuitable on treatment day across all four procedure categories — and during short-term aftercare — due to irritation risk.
The same treatment-day restriction applies to: azelaic acid, benzoyl peroxide, cysteamine, glycolic acid, hydroquinone, lactic acid, and salicylic acid. This isn’t a permanent avoidance recommendation — it’s a timing protocol. Retinoids and acids belong in the patient’s regimen before and after the healing window; the issue is specifically when to pause and when to resume.
For skin of color patients, this timing matters clinically. Compromised barrier combined with active inflammation is a post-inflammatory hyperpigmentation trigger, particularly following ablative procedures, RF microneedling, and chemical peels. The panel’s conclusion notes PIH risk in skin of color explicitly as a driver of the retinoid and acid avoidance recommendation during the healing phase.
The practical application is straightforward: establish what your patients are using at intake (retinoids, acids, anything with significant irritation potential), tell them when to pause, and have a defined post-procedure product list that maps to the consensus ingredients.
You don’t need a private label line. Ceramides, HA, niacinamide, and panthenol are found in many well-formulated available products. The value is in knowing what to recommend and why — and in having that recommendation documented as a clinical standard rather than handed off verbally in the aftercare instructions.
One important note: sunscreen is not among the ingredients this consensus evaluated, but it belongs in any post-procedure protocol as a standard-of-care recommendation. SPF use during the followup phase supports healing and directly reduces UV-triggered PIH risk — particularly relevant for skin of color patients and for ablative procedure recovery.
This kind of integrated skincare curriculum — how ingredients interact with procedures at specific time points, how to counsel patients on skin of color — is part of the comprehensive training in IAPAM’s Certified Aesthetic Provider program. For providers earlier in the process of building out their treatment menu, the Practice Accelerator Program covers foundational skincare integration as part of the broader aesthetic practice curriculum.
What skincare should patients use after RF microneedling or laser treatment?
In the immediate aftercare phase (Day 1–7), the consensus supports ceramides, hyaluronic acid, niacinamide, and panthenol as well-tolerated options across energy-based procedures. Vitamin C is also highly ranked for treatment day and aftercare. Avoid retinoids, glycolic acid, lactic acid, and salicylic acid during this phase — these can be reintroduced during the followup phase (Day 8–28) once re-epithelialization is complete.
When can patients resume retinol after an aesthetic procedure?
The consensus recommends avoiding retinoids on treatment day and during short-term aftercare (Day 1–7). Resumption is appropriate during the followup phase — generally after Day 7, once the skin barrier has recovered. For ablative procedures or patients with skin of color, a conservative approach to timing is warranted given PIH risk. Clinical judgment on individual patient healing should guide the exact timing.
What skincare ingredients reduce the risk of PIH after procedures in darker skin tones?
During the healing phase, the priority is barrier support with well-tolerated ingredients: ceramides, hyaluronic acid, niacinamide, and panthenol. Niacinamide has pigment-modulating properties in addition to its anti-inflammatory and barrier-supporting effects, making it particularly relevant for skin of color patients. Strict avoidance of retinoids and acids on treatment day and during aftercare is the most direct PIH risk mitigation strategy the consensus identifies.
Is niacinamide safe to use after microneedling or chemical peels?
Yes. Niacinamide reached consensus as appropriate across all four procedure categories and all four time points, including non-energy-based procedures with barrier disruption (which includes microneedling and chemical peels). It is one of the most broadly supported actives in this consensus, with anti-inflammatory, barrier-supporting, and pigment-modulating properties that are useful in the post-procedure period.
What’s the difference between ablative and non-ablative skincare protocols?
The core ingredient list for both overlaps significantly — ceramides, HA, niacinamide, and peptides are appropriate at all time points for both categories. The differences show up in degree of caution. Ablative procedures cause greater barrier disruption and carry higher PIH risk, so the avoidance of retinoids and acids on treatment day is especially important, and the timeline for reintroduction should be more conservative. Non-ablative energy-based procedures like RF microneedling also warrant treatment-day avoidance, but barrier recovery is generally faster.
Should patients stop using acids before an aesthetic procedure?
The consensus identifies glycolic acid, lactic acid, salicylic acid, and azelaic acid as unsuitable on treatment day across all four procedure categories. The pretreatment phase (Day −14 to −1) does not carry the same restriction — these ingredients are not flagged as inappropriate before the procedure. A practical approach: advise patients to discontinue acids on the day of treatment and during the aftercare window, then resume once the skin barrier has recovered.
Discover proven techniques and industry insights to elevate your aesthetic practice. This comprehensive ebook covers essential protocols, patient safety, and advanced injection strategies used by top practitioners.
References:
Contains: Emerging trends, expert discussions, recommendations, technique comparisons… and more!